Invention Grant
- Patent Title: Anti-DLL3 antibody drug conjugates
-
Application No.: US15616800Application Date: 2017-06-07
-
Publication No.: US09855343B2Publication Date: 2018-01-02
- Inventor: Robert A. Stull , Laura Saunders , Scott J. Dylla , Orit Foord , David Liu , Michael Torgov , Hui Shao
- Applicant: ABBVIE STEMCENTRX LLC
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Stemcentrx LLC
- Current Assignee: AbbVie Stemcentrx LLC
- Current Assignee Address: US IL North Chicago
- Agency: Womble Bond Dickinson (US) LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; C12P21/08 ; A61K47/48 ; C07K16/30 ; G01N33/574 ; A61K45/06 ; A61K31/5517 ; C07K16/28 ; A61K51/10 ; A61K31/551 ; A61K39/00
Abstract:
Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
Public/Granted literature
- US20170274094A1 DLL3 MODULATORS AND METHODS OF USE Public/Granted day:2017-09-28
Information query
